ORCHESTRA BIOMED HOLDINGS IN (OBIO) Stock Analyst Ratings
NASDAQ:OBIO - Nasdaq - US68572M1062 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to OBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.84. This target is 397.94% above the current price.
OBIO was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about OBIO.
In the previous month the buy percentage consensus was at a similar level.
OBIO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-22 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-20 | BTIG | Initiate | Buy |
| 2025-03-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-02 | Barclays | Initiate | Overweight |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-22 | HC Wainwright & Co. | Initiate | Buy |
| 2024-07-25 | B. Riley Securities | Initiate | Buy |
| 2024-06-12 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-03-28 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-01-19 | Jefferies | Initiate | Buy |
| 2023-08-11 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-08-09 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-05-15 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-02-24 | Piper Sandler | Initiate | Overweight |
| 2023-02-07 | Chardan Capital | Initiate | Buy |